The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior

Neuropharmacology

Volumn 63, Issue 2, 2012, Pages 202-210

  Fogaça, Manoela V ^a   Aguiar, Daniele C ^b   Moreira, Fabrício A ^b   Guimarães, Francisco S ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Anandamide; Anxiety; Cannabinoid; CB1 receptors; Prefrontal cortex; TRPV1 receptors; Vanilloid

Indexed keywords

CANNABINOID 1 RECEPTOR AGONIST; ENDOCANNABINOID; VANILLOID RECEPTOR 1;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BRAIN REGION; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MALE; MAZE TEST; NERVE ENDING; NONHUMAN; PREFRONTAL CORTEX; PRELIMBIC MEDIAL PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; ARACHIDONIC ACIDS; BEHAVIOR, ANIMAL; CAPSAICIN; ENDOCANNABINOIDS; MALE; PIPERIDINES; PREFRONTAL CORTEX; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; TRPV CATION CHANNELS;

EID: 84861993153     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.03.007     Document Type: Article

References (84)

1. Acs, G., Palkovits, M., Blumberg, P.M., 1994. [3H]Resiniferatoxin binding by the human vanilloid (capsaicin) receptor. Brain Res. Mol. Brain Res. 23, 185-190.
2. Aguiar, D.C., Terzian, A.L., Guimaraes, F.S., Moreira, F.A., 2009. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats. Psychopharmacology (Berl) 205, 217-225.
3. Appendino, G., Harrison, S., De Petrocellis, L., Daddario, N., Bianchi, F., Schiano Moriello, A., Trevisani, M., Benvenuti, F., Geppetti, P., Di Marzo, V., 2003. Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists. Br. J. Pharmacol. 139, 1417-1424.
4. Baker, C.L., McDougall, J.J., 2004. The cannabinomimetic arachidonyl-2-chloroethylamide (ACEA) acts on capsaicin-sensitive TRPV1 receptors but not cannabinoid receptors in rat joints. Br. J. Pharmacol. 142, 1361-1367.
5. Berrendero, F., Maldonado, R., 2002. Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol. Psychopharmacology (Berl) 163, 111-117.
6. Campos, A.C., Ferreira, F.R., Guimarães, F.S., Lemos, J.I., 2010. Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience. Neuroscience 167, 238-246.
7. Casarotto, P., Terzian, A.L., Aguiar, D.C., Zangrossi, H., Guimaraes, F.S., Wotjak, C.T., Moreira, F.A., 2012. Opposing roles for cannabinoid receptor type-1 (CB1) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats. Neuropsychopharmacology 37, 478-486.
8. Chung, J.M., Lee, K.H., Hori, Y., Willis, W.D., 1985. Effects of capsaicin applied to a peripheral nerve on the responses of primate spinothalamic tract cells. Brain Res. 329, 27-38.
9. Cristino, L., de Petrocellis, L., Pryce, G., Baker, D., Guglielmotti, V., Di Marzo, V., 2006. Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain. Neuroscience 139, 1405-1415.
10. Davis, J.F., Loos, M., Di Sebastiano, A.R., Brown, J.L., Lehman, M.N., Coolen, L.M., 2010. Lesions of the medial prefrontal cortex cause maladaptive sexual behavior in male rats. Biol. Psychiatry 67, 1199-1204.
11. de Novellis, V., Vita, D., Gatta, L., Luongo, L., Bellini, G., De Chiaro, M., Marabese, I., Siniscalco, D., Boccella, S., Piscitelli, F., Di Marzo, V., Palazzo, E., Rossi, F., Maione, S., 2011. The blockade of the transient receptor potential vanilloid type 1 and fatty acid amide hydrolase decreases symptoms and central sequelae in the medial prefrontal cortex of neuropathic rats. Mol. Pain 7, 7.
12. de Oliveira, R.W., Del Bel, E.A., Guimarães, F.S., 2000. Behavioral and c-fos expression changes induced by nitric oxide donors microinjected into the dorsal periaqueductal gray. Brain Res. Bull. 51, 457-464.
13. de Visser, L., Baars, A.M., van't Klooster, J., van den Bos, R., 2011. Transient inactivation of the medial prefrontal cortex affects both anxiety and decision-making in male wistar rats. Front. Neurosci. 5, 102.
14. Di Marzo, V., 2009. The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation. Pharmacol. Res. 60, 77-84.
15. Di Marzo, V., Gobbi, G., Szallasi, A., 2008. Brain TRPV1: a depressing TR(i)P down memory lane? Trends Pharmacol. Sci. 29, 594-600.
16. Egertová, M., Giang, D.K., Cravatt, B.F., Elphick, M.R., 1998. A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1receptor in rat brain. Proc. Biol. Sci. 265, 2081-2085.
17. File, S.E., 1992. Behavioural detection of anxiolytic action. In: Elliot, J.M., Heal, D.J., Marsden, C.A. (Eds.), Experimental Approaches to Anxiety and Depression. Wiley, New York, pp. 25-44.
18. Fitzpatrick, C.J., Knox, D., Liberzon, I., 2011. Inactivation of the prelimbic cortex enhances freezing induced by trimethylthiazoline, a component of fox feces. Behav. Brain Res. 221, 320-323.
19. Genn, R.F., Tucci, S., Marco, E.M., Viveros, M.P., File, S.E., 2004. Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test. Pharmacol. Biochem. Behav. 77, 567-573.
20. Gerdeman, G., Lovinger, D.M., 2001. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J. Neurophysiol. 85, 468-471.
21. Giuliani, D., Ferrari, F., Ottani, A., 2000. The cannabinoid agonist HU 210 modifies rat behavioural responses to novelty and stress. Pharmacol. Res. 41, 47-53.
22. Grueter, B.A., Brasnjo, G., Malenka, R.C., 2010. Postsynaptic TRPV1 triggers cell typespecific long-term depression in the nucleus accumbens. Nat. Neurosci. 13, 1519-1525.
23. Guimarães, F.S., Carobrez, A.P., De Aguiar, J.C., Graeff, F.G., 1991. Anxiolytic effect in the elevated plus-maze of the NMDA receptor antagonist AP7 microinjected into the dorsal periaqueductal grey. Psychopharmacology (Berl) 103, 91-94.
24. Haller, J., Varga, B., Ledent, C., Freund, T.F., 2004. CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav. Pharmacol. 15, 299-304.
25. Handley, S.L., Mithani, S., 1984. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Arch. Pharmacol. 327, 1-5.
26. Heidbreder, C.A., Groenewegen, H.J., 2003. The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics. Neurosci. Biobehav Rev. 27, 555-579.
27. Hillard, C.J., Manna, S., Greenberg, M.J., DiCamelli, R., Ross, R.A., Stevenson, L.A., Murphy, V., Pertwee, R.G., Campbell, W.B., 1999. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J. Pharmacol. Exp. Ther. 289, 1427-1433.
28. Huang, C.C., Lo, S.W., Hsu, K.S., 2001. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons. J. Physiol. 532, 731-748.
29. Jinks, A.L., McGregor, I.S., 1997. Modulation of anxiety-related behaviours following lesions of the prelimbic or infralimbic cortex in the rat. Brain Res. 772, 181-190.
30. Karlsson, U., Sundgren-Andersson, A.K., Johansson, S., Krupp, J.J., 2005. Capsaicin augments synaptic transmission in the rat medial preoptic nucleus. Brain Res. 1043, 1-11.
31. Kasckow, J.W., Mulchahey, J.J., Geracioti Jr., T.D., 2004. Effects of the vanilloid agonist olvanil and antagonist capsazepine on rat behaviors. Prog. Neuropsychopharmacol. Biol. Psychiatry 28, 291-295.
32. Liapi, A., Wood, J.N., 2005. Extensive co-localization and heteromultimer formation of the vanilloid receptor-like protein TRPV2 and the capsaicin receptor TRPV1 in the adult rat cerebral cortex. Eur. J. Neurosci. 22, 825-834.
33. Lisboa, S.F., Stecchini, M.F., Corrêa, F.M., Guimarães, F.S., Resstel, L.B., 2010. Different role of the ventral medial prefrontal cortex on modulation of innate and associative learned fear. Neuroscience 171, 760-768.
34. Maccarrone, M., Rossi, S., Bari, M., De Chiara, V., Fezza, F., Musella, A., Gasperi, V., Prosperetti, C., Bernardi, G., Finazzi-Agrò, A., Cravatt, B.F., Centonze, D., 2008. Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat. Neurosci. 11, 152-159.
35. Mahmud, A., Santha, P., Paule, C.C., Nagy, I., 2009. Cannabinoid 1 receptor activation inhibits transient receptor potential vanilloid type 1 receptor-mediated cationic influx into rat cultured primary sensory neurons. Neuroscience 162, 1202-1211.
36. Maione, S., Bisogno, T., de Novellis, V., Palazzo, E., Cristino, L., Valenti, M., Petrosino, S., Guglielmotti, V., Rossi, F., Di Marzo, V., 2006. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. J. Pharmacol. Exp. Ther. 316, 969-982.
37. Marco, E.M., Pérez-Alvarez, L., Borcel, E., Rubio, M., Guaza, C., Ambrosio, E., File, S.E., Viveros, M.P., 2004. Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats. Behav. Pharmacol.15, 21-27.
38. Marín, S., Marco, E., Biscaia, M., Fernández, B., Rubio, M., Guaza, C., Schmidhammer, H., Viveros, M.P., 2003. Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male rats. Pharmacol. Biochem. Behav. 74, 649-656.
39. Marsch, R., Foeller, E., Rammes, G., Bunck, M., Kössl, M., Holsboer, F., Zieglgänsberger, W., Landgraf, R., Lutz, B., Wotjak, C.T., 2007. Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J. Neurosci. 27, 832-839.
40. Marsh, S.J., Stansfeld, C.E., Brown, D.A., Davey, R., McCarthy, D., 1987. The mechanism of action of capsaicin on sensory C-type neurons and their axons in vitro. Neuroscience 23, 275-289.
41. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C., Bonner, T.I., 1990. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
42. Mezey, E., Toth, Z.E., Cortright, D.N., Arzubi, M.K., Krause, J.E., Elde, R., Guo, A., Blumberg, P.M., Szallasi, A., 2000. Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human. Proc. Natl. Acad. Sci. U S A 97, 3655-3660.
43. Micale, V., Cristino, L., Tamburella, A., Petrosino, S., Leggio, G.M., Drago, F., Di Marzo, V., 2009. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Neuropsychopharmacology 34, 593-606.
44. Miguel, T.T., Nunes-de-Souza, R.L., 2008. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice. Brain Res. 1240, 39-46.
45. Molchanov, M.L., Guimaraes, F.S., 2002. Anxiolytic-like effects of AP7 injected into the dorsolateral or ventrolateral columns of the periaqueductal gray of rats. Psychopharmacology (Berl) 160, 30-38.
46. Moreira, F.A., Lutz, B., 2008. The endocannabinoid system: emotion, learning and addiction. Addict. Biol. 13, 196-212.
47. Moreira, F.A., Aguiar, D.C., Guimarães, F.S., 2007. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaquedutal gray. Neuropharmacology 52, 958-965.
48. Musella, A., De Chiara, V., Rossi, S., Prosperetti, C., Bernardi, G., Maccarrone, M., Centonze, D., 2009. TRPV1 channels facilitate glutamate transmission in the striatum. Mol. Cell Neurosci. 40, 89-97.
49. Onaivi, E.S., Green, M.R., Martin, B.R., 1990. Pharmacological characterization of cannabinoids in the elevated plus-maze. J. Pharmacol. Exp. Ther. 253, 1002-1009.
50. Oshita, K., Inoue, A., Tang, H.B., Nakata, Y., Kawamoto, M., Yuge, O., 2005. CB1 cannabinoid receptor stimulation modulates transient receptor potential vanilloid receptor 1 activities in calcium influx and substance P Release in cultured rat dorsal root ganglion cells. J. Pharmacol. Sci. 97, 377-385.
51. Paxinos, G., Watson, C., 2005. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
52. Pertwee, R.G., Howlett, A.C., Abood, M.E., Alexander, S.P., Di Marzo, V., Elphick, M.R., Greasley, P.J., Hansen, H.S., Kunos, G., Mackie, K., Mechoulam, R., Ross, R.A., 2010. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacol. Rev. 62, 588-631.
53. Peters, J., Thoma, P., Koch, B., Schwarz, M., Daum, I., 2009. Impairment of verbal recollection following ischemic damage to the right anterior hippocampus. Cortex 45, 592-601.
54. Price, T.J., Patwardhan, A., Akopian, A.N., Hargreaves, K.M., Flores, C.M., 2004. Modulation of trigeminal sensory neuron activity by the dual cannabinoidvanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. Br. J. Pharmacol. 141, 1118-1130.
55. Puente, N., Cui, Y., Lassalle, O., Lafourcade, M., Georges, F., Venance, L., Grandes, P., Manzoni, O.J., 2011 Nov 6. Polymodal activation of the endocannabinoid system in the extended amygdala. Nat. Neurosci.. doi:10.1038/nn.2974
56. Resstel, L.B., Corrêa, F.M., Guimarães, F.S., 2008. The expression of contextual fear conditioning involves activation of an NMDA receptor-nitric oxide pathway in the medial prefrontal cortex. Cereb. Cortex 18, 2027-2035.
57. Roberts, J.C., Davis, J.B., Benham, C.D., 2004. [3H]Resiniferatoxin autoradiography in the CNS of wild-type and TRPV1 null mice defines TRPV1 (VR-1) protein distribution. Brain Res. 995, 176-183.
58. Roohbakhsh, A., Keshavarz, S., Hasanein, P., Rezvani, M.E., Moghaddam, A.H., 2009. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours. Basic Clin. Pharmacol. Toxicol. 105, 333-338.
59. Ross, R.A., 2003. Anandamide and vanniloid TRPV1 receptors. Br. J. Pharmacol. 140, 790-801.
60. Rubino, T., Sala, M., Viganò, D., Braida, D., Castiglioni, C., Limonta, V., Guidali, C., Realini, N., Parolaro, D., 2007. Cellular mechanisms underlying the anxiolytic effect of low doses of peripheral Delta9- tetrahydrocannabinol in rats. Neuropsychopharmacology 32, 2036-2045.
61. Rubino, T., Realini, N., Castiglioni, C., Guidali, C., Viganó, D., Marras, E., Petrosino, S., Perletti, G., Maccarrone, M., Di Marzo, V., Parolaro, D., 2008a. Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb. Cortex 18, 1292-1301.
62. Rubino, T., Guidali, C., Vigano, D., Realini, N., Valenti, M., Massi, P., Parolaro, D., 2008b. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. Neuropharmacology 54, 151-160.
63. Santos, C.J., Stern, C.A., Bertoglio, L.J., 2008. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus. Behav. Pharmacol. 19, 357-360.
64. Smart, D., Jerman, J.C., 2000. Anandamide: an endogenous activator of the vanilloid receptor. Trends Pharmacol. Sci. 21, 134.
65. Smart, D., Gunthorpe, M.J., Jerman, J.C., Nasir, S., Gray, J., Muir, A.I., Chambers, J.K., Randall, A.D., Davis, J.B., 2000. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol. 129 (2), 227-233.
66. Sotres-Bayon, F., Quirk, G.J., 2010. Prefrontal control of fear: more than just extinction. Curr. Opin. Neurobiol. 20, 231e235.
67. Starowicz, K., Maione, S., Cristino, L., Palazzo, E., Marabese, I., Rossi, F., de Novellis, V., Di Marzo, V., 2007. Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. J. Neurosci. 27, 13739-13749.
68. Starowicz, K., Cristino, L., Di Marzo, V., 2008. TRPV1 receptors in the central nervous system: potential for previously unforeseen therapeutic applications. Curr. Pharm. Des. 14, 42-54.
69. Szabo, B., Schlicker, E., 2005. Effects of cannabinoids on neurotransmission. Handb. Exp. Pharmacol. 168, 327-365.
70. Szabo, T., Biro, T., Gonzalez, A.F., Palkovits, M., Blumberg, P.M., 2002. Pharmacological characterization of vanilloid receptor located in the brain. Brain Res. Mol. Brain Res. 98, 51-57.
71. Tasker, J., 2004. Endogenous cannabinoids take the edge off neuroendocrine responses to stress. Endocrinology 145, 5429-5430.
72. Terzian, A.L., Aguiar, D.C., Guimaraes, F.S., Moreira, F.A., 2009. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray. Eur. Neuropsychopharmacol. 19, 188-195.
73. Tóth, A., Boczan, J., Kedei, N., Lizanecz, E., Bagi, Z., Papp, Z., Edes, I., Csiba, L., Blumberg, P.M., 2005. Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain. Brain Res. Mol. Brain Res. 135, 162-168.
74. Tóth, A., Blumberg, P.M., Boczán, J., 2009. Anandamide and the vanilloid receptor (TRPV1). Vitam. Horm. 81, 389-419.
75. Treit, D., Menard, J., Royan, C., 1993. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44, 463-469.
76. Urigüen, L., Pérez-Rial, S., Ledent, C., Palomo, T., Manzanares, J., 2004. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 46, 966-973.
77. Vertes, R.P., 2004. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse 51, 32-58.
78. Viveros, M.P., Marco, E.M., File, S.E., 2005. Endocannabinoid system and stress and anxiety responses. Pharmacol. Biochem. Behav. 81, 331-342.
79. Vogel, J.R., Beer, B., Clody, D.E., 1971. A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21, 1-7.
80. Wang, S.J., 2003. Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes. Eur. J. Pharmacol. 469, 47-55.
81. Xing, J., Li, J., 2007. TRPV1 receptor mediates glutamatergic synaptic input to dorsolateral periaqueductal gray (dl-PAG) neurons. J. Neurophysiol. 97, 503-511.
82. Zarrindast, M.R., Sarahroodi, S., Arzi, A., Khodayar, M.J., Taheri-Shalmani, S., Rezayof, A., 2008. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system. Behav. Pharmacol. 19, 716-723.
83. Zschenderlein, C., Gebhardt, C., von Bohlen Und Halbach, O., Kulisch, C., Albrecht, D., 2011. Capsaicin-induced changes in LTP in the lateral amygdala are mediated by TRPV1. PLoS One 6, e16116.
84. Zygmunt, P.M., Petersson, J., Andersson, D.A., Chuang, H., Sørgård, M., Di Marzo, V., Julius, D., Högestätt, E.D., 1999. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400, 452-457.